BEATW
NASDAQ
$0.05
HeartBeam Inc - Warrants (31/10/2026) (BEATW)
Heartbeam Inc. Warrant (BEATW) represents an innovative investment opportunity associated with Heartbeam Inc., a cutting-edge healthcare technology company focused on transforming cardiac diagnostics through the integration of artificial intelligence and digital health solutions. By enhancing the accuracy of myocardial infarction diagnoses, Heartbeam's platform facilitates timely interventions that significantly improve patient outcomes. With the increasing demand for remote monitoring and telehealth services in the cardiovascular sector, Heartbeam is well-positioned to capitalize on market growth, making BEATW an attractive consideration for institutional investors seeking exposure to advanced medical technologies with substantial potential for impact.
This company is also listed under the following ticker: BEAT.
Beta (5Y)
-0.29
Price Chart
Profitability
EPS-$0.50
Growth & Risk
Beta (5Y)-0.29
Sharpe Ratio-0.12